Master of Science (M.Sc.) (Medical Biometry / Biostatistics)
2006 - 2009
DKFZ German Cancer Research Center
Doctor of Philosophy - PhD (Epidemiology)
1998 - 2001
Ruprecht-Karls-Universität Heidelberg
Doctor of Medicine (MD) (Medicine)
1993 - 2000
Ruprecht-Karls-Universität Heidelberg
Master of Science (M.Sc.) (Medical Informatics)
1985 - 1992
Hochschule Heilbronn - Hochschule für Technik und Wirtschaft
Master of Science (M.Sc.) (Medical Informatics)
1985 - 1992
Amirkabir University of Technology - Tehran Polytechnic
Petrochemical Engineering
1983 - 1984
Keyvan Mehr's Skills
Immunology
Immuno-oncology
Oncology
Vaccines
Clinical Development
Clinical Trials
Clinical Research
Clinical Pharmacology
Drug Development
Pharmacovigilance
Keyvan Mehr's Summary
Keyvan Mehr, based in Darmstadt, HE, DE, is currently a Executive Medical Director and Global Clinical Program Head Immuno-Oncology at Healthcare Business of Merck, bringing experience from previous roles at Healthcare Business of Merck, KTMedConsult, Molecular Partners AG, Zurich, Switzerland and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Keyvan Mehr holds a 2006 - 2009 Master of Science (M.Sc.) in Medical Biometry / Biostatistics @ Ruprecht-Karls-Universität Heidelberg. With a robust skill set that includes Immunology, Immuno-oncology, Oncology, Vaccines, Clinical Development and more, Keyvan Mehr contributes valuable insights to the industry. Keyvan Mehr has 2 emails and 1 mobile phone number on RocketReach.